HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief

This article was originally published in The Rose Sheet

Executive Summary

Revlon is closing facilities and reducing headcount to “drive operating efficiencies,” the firm says. More news in brief.

You may also be interested in...

Physicians Formula Goes To Wet N Wild Owner Markwins For $75 Mil.

Markwins International has acquired Physicians Formula Holdings, offering roughly $10 million more than previous suitor Swander Pace Capital. The merger “will strengthen the combined portfolio of brands,” Physicians Formula CEO Ingrid Jackel says.

Physicians Formula Bought For $65 Mil. By Private Equity

Swander Pace Capital pads its personal care portfolio with the acquisition of skin care and color cosmetics brand Physicians Formula.

Coty Growth Driven By On-Trend New Products

Marketer of Sally Hansen and Rimmel attributes its strong growth in 2011 to staying ahead of trends in the marketplace. Coty Inc. expects more of the same for 2012, along with a highly anticipated Lady Gaga scent, expected to be the “biggest fragrance launch this year.”

Related Content

Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts